This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Shigeyoshi Ura: Innovator in Therapeutic Treatments
Introduction
Shigeyoshi Ura is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of veterinary medicine, particularly in the treatment of swine diseases. His innovative approach has led to the development of a unique therapeutic agent aimed at combating swine pleuropneumonia.
Latest Patents
Ura holds a patent for a therapeutic treatment for swine pleuropneumonia. This invention relates to a novel prophylactic and therapeutic agent that comprises a bicozamycin ester. The formula includes a component where R represents either a benzoyl group or a cyclohexanecarbonyl group. This patent showcases Ura's commitment to improving animal health and welfare.
Career Highlights
Shigeyoshi Ura is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been able to apply his expertise in pharmaceutical development. His work has been instrumental in advancing therapeutic options for veterinary applications. Ura's dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Ura has collaborated with notable colleagues such as Satoru Nakano and Masaaki Okada. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.
Conclusion
Shigeyoshi Ura's contributions to veterinary medicine through his innovative patent for swine pleuropneumonia treatment highlight his role as a significant inventor. His work continues to influence the field and improve animal health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
